Xenon Pharmaceuticals(XENE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

XENE Xenon Pharmaceuticals

Post-Mkt 10-16 16:50:12 EDT

33.49

-0.84

-2.45%

盘后33.00

-0.49-1.46%

16:29 EDT

High34.38	Low33.38	Vol1.07M
Open34.34	D1 Closing34.33	Amplitude2.90%
Mkt Cap3.24B	Tradable Cap3.20B	Total Shares96.64M
T/O35.99M	T/O Rate1.12%	Tradable Shares95.45M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"XENE","market":"US","secType":"STK","nameCN":"Xenon Pharmaceuticals","latestPrice":33.49,"timestamp":1792180800000,"preClose":34.33,"halted":0,"volume":1070504,"hourTrading":{"tag":"盘后","latestPrice":33,"preClose":33.49,"latestTime":"16:29 EDT","volume":17477,"amount":584733.05733,"timestamp":1792182566031,"change":-0.49,"changeRate":-0.014631,"amplitude":0.033144},"delay":0,"changeRate":-0.02446839498980473,"floatShares":95449436,"shares":96642822,"eps":-4.706128,"marketStatus":"Post-Mkt","change":-0.84,"latestTime":"10-16 16:50:12 EDT","open":34.34,"high":34.375,"low":33.38,"amount":35992322,"amplitude":0.028983,"askPrice":34.14,"askSize":58,"bidPrice":32.84,"bidSize":60,"shortable":3,"etf":0,"ttmEps":-4.706128,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1792195200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1415163600000,"exchange":"NASDAQ","adjPreClose":34.33,"preHourTrading":{"tag":"盘前","latestPrice":34.28,"preClose":34.33,"latestTime":"09:29 EDT","volume":3212,"amount":110667.42038000001,"timestamp":1792157399999,"change":-0.05,"changeRate":-0.001456,"amplitude":0.018643},"postHourTrading":{"tag":"盘后","latestPrice":33,"preClose":33.49,"latestTime":"16:29 EDT","volume":17477,"amount":584733.05733,"timestamp":1792182566031,"change":-0.49,"changeRate":-0.014631,"amplitude":0.033144},"volumeRatio":0.820189,"impliedVol":0.6356,"impliedVolPercentile":0.6375},"requestUrl":"/m/hq/s/XENE","defaultTab":"news","newsList":[{"id":"2674387708","title":"Bank of America Securities Sticks to Their Buy Rating for Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674387708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674387708?lang=en_us&edition=fundamental","pubTime":"2026-10-12 20:17","pubTimestamp":1791807424,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Jason Gerberry maintained a Buy rating on Xenon today and set a price target of $77.00. Gerberry covers the Heal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-buy-rating-for-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-buy-rating-for-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","XENE","BAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673087056","title":"Xenon Pharmaceuticals Coverage Assumed by Guggenheim at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2673087056","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673087056?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:22","pubTimestamp":1791289320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XENE/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","BK4139","IBRN","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673841800","title":"Xenon Pharmaceuticals assumed with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2673841800","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673841800?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:25","pubTimestamp":1791231927,"startTime":"0","endTime":"0","summary":"Guggenheim assumed coverage of Xenon Pharmaceuticals (XENE), which was previously covered by Yatin Suneja, with a Buy rating and $73 price target T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-assumed-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-assumed-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XENE","IBRN","BK4139","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672467557","title":"Xenon Grants 17,850 Inducement Stock Options, 10,500 RSUs to New Hires Under NASDAQ Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2672467557","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672467557?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:01","pubTimestamp":1790971282,"startTime":"0","endTime":"0","summary":"Xenon grants 17,850 inducement stock options, 10,500 RSUs to new hires under Nasdaq ruleXenon Pharmaceuticals issued inducement equity awards to eight new non-officer employees, totaling 17,850 share ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL4TdRtw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","IBRN","SG9999014021.USD","NDAQ","XENE","LU0314104364.USD","IE00BN0W2W23.USD","SBIO","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","LU2210150020.SGD","BCDF","LU2095319765.USD","SG9999014005.SGD","BK4585","BK4139","IE00BQXX3C00.GBP","SG9999014013.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749997","title":"Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749997","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749997?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:01","pubTimestamp":1790971260,"startTime":"0","endTime":"0","summary":"VANCOUVER, BC and BOSTON, MA, Oct.  02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical devel","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3374010/33485/en/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XENE","BK4139","SBIO","LCLG","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672876399","title":"Xenon's AZK Approval Path Unlikely to Be Hurt by Safety Issues, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672876399","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672876399?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:02","pubTimestamp":1790866926,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals'  safety data has raised investor concerns about a potential Food and Drug Administration warning for azetukalner, or AZK, though approval appears largely unaffected, RBC Capital Markets said Thursday in a report.Recent updates from the company's psychiatry program have raised investor concerns that neuropsychological adverse events may lead the FDA to add a warning, potentially even a boxed warning, to AZK's focal-onset seizures label, RBC said. Investors are also concerned that this could hurt AZK's commercial uptake and weigh on the stock, the report said.Based on historical precedent, AZK's data to date, and recent FDA feedback, RBC said it doesn't believe AZK is likely to receive a molecule-specific boxed warning, and that approval or commercial uptake isn't facing major risk.\"We continue to see $1.5 billion focal-onset seizures potential, justifying a higher valuation, and while acknowledging it may take time for investors to be reassured, view recent weakne","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","XENE","SBIO","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672813750","title":"Xenon Pharma CEO Ian Mortimer Acquires $1,121,400 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672813750","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672813750?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:20","pubTimestamp":1790860804,"startTime":"0","endTime":"0","summary":"Xenon Pharma CEO Ian Mortimer acquires $1,121,400 in common sharesXenon Pharmaceuticals President and CEO Ian Mortimer bought 30,000 common shares at USD 37.38 each.Directly held stake rose to 49,923 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLr2q46:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Xenon Pharma CEO Ian Mortimer Acquires $1,121,400 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SBIO","IBRN","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671181299","title":"Defence Therapeutics Appoints Ex-Xenon CFO Sherry Aulin to Board, Audit Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2671181299","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671181299?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:16","pubTimestamp":1790666165,"startTime":"0","endTime":"0","summary":"Defence Therapeutics appoints ex-Xenon CFO Sherry Aulin to board, audit committeeDefence Therapeutics appointed finance executive Sherry Aulin to its board, adding her to the audit committee.Aulin was","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL177fM4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","BK4139","SBIO","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670283036","title":"Xenon Pharmaceuticals Inc. : Jefferies Cuts Target Price to $90 from $100","url":"https://stock-news.laohu8.com/highlight/detail?id=2670283036","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670283036?lang=en_us&edition=fundamental","pubTime":"2026-09-28 12:09","pubTimestamp":1790568563,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I06J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XENE","SBIO","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669198606","title":"Xenon Pharmaceuticals Presents at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2669198606","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669198606?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:01","pubTimestamp":1790020877,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals presents at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit fireside chatXenon Pharmaceuticals will present at the TD Cowen Novel Mechanisms in Neuropsychiatry & E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDLbHYW3r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4585","BK4139","IE00BN0W2T93.GBP","LU2095319765.USD","XENE","LU2210149790.SGD","IE00BQXX3D17.EUR","BCDF","IE00BKPKM429.USD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","BK4588","NDAQ","IBRN","LU0314104364.USD","LU2210150020.SGD","BK4112","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014005.SGD","SBIO","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668097355","title":"US Stocks-S&P 500, NASDAQ Advance, Turning the Page on a Tumultuous Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2668097355","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668097355?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:20","pubTimestamp":1789762837,"startTime":"0","endTime":"0","summary":"US STOCKS-S&P 500, Nasdaq advance, turning the page on a tumultuous weekNEW YORK, Sept 18 (Reuters)-Wall Street closed a volatile week on a muted note on Friday as benchmark US Treasury yields topped ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL6N45A15E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","BK4139","IBRN","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973504","title":"U.S. Small Caps Close Lower; Xenon Pharmaceuticals Posts Biggest Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973504?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:20","pubTimestamp":1789762800,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies fell Friday, as the Russell 2000 Index declined 0.5%, and the S&P Small Cap 600 Index was down 0.5%.Among companies with a market value of $1 billion to $6.7 billion, Xenon Pharmaceuticals Inc. was the biggest laggard during the session, dropping 31%, followed by shares of Genius Sports Ltd., which dropped 13%. Shares of NuScale Power Corp. dropped 8.5%, SL Science Holding Ltd. shares tumbled 8.0%, and Rush Street Interactive Inc. plunged 7.7%.Securitize Corp. was the best performer, surging 22%, followed by Bitdeer Technologies Group, which jumped 15%. MARA Holdings Inc. shares jumped 14%, Sharplink Inc. surged 13%, and shares of Sigma Lithium Corp. surged 12%.Major U.S. stock indexes ended Friday mixed as the Nasdaq Composite Index added 0.4%. Meanwhile, the S&P 500 Index added 0.2%, and the Dow Jones Industrial Average fell 0.2%.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SBIO","IBRN","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668273689","title":"Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668273689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668273689?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:30","pubTimestamp":1789749010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Corcept Therapeutics (CORT) and Xenon (XENE) with bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-corcept-therapeutics-cort-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-corcept-therapeutics-cort-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","BK4581","BK4137","CORT","SBIO","BK4139","XENE","HCSG","LU0029874061.USD","XBI","LABU","LU0566484027.USD","LU1559883803.SGD","BK4588","BK4532","IBRN","BK4007","XLV","FBT","LU0128526141.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668922682","title":"U.S. Stocks on the MOVE-Halozyme Therapeutics, Etsy, Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2668922682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668922682?lang=en_us&edition=fundamental","pubTime":"2026-09-18 23:52","pubTimestamp":1789746775,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Halozyme Therapeutics, Etsy, NetflixSeptember 18 (Reuters)-Wall Street's main indexes fell on Friday in the final stretch of a turbulent week, as investors assessed shifti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL6N45A0YO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AUMI","GLDN","SGDM","XENE","AGMI","DSP","LU0788108826.HKD","PYZ","CWVX","DT","CAVA","CRWU","MLPI","TPZ","STLD","CORD","TRUM","LU1223082519.USD","MLPX","UMI","GDMN","TRGP","FMTL","AFK","LU0278409577.USD","SBIO","NEM","NWMX","SLVP","BK4570","PICK","CRWG","LU0154245673.USD","NEMG","AU","GDX","CRWV","HALO","AUAU","BK4209","FFOX","ETSY","PXI","SLX","STUB","LU2361045086.USD","IBRN","NUE","CWII","CRWX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668192426","title":"Xenon Pharmaceuticals' Azetukalner Retains Core Epilepsy Value, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2668192426","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668192426?lang=en_us&edition=fundamental","pubTime":"2026-09-18 23:21","pubTimestamp":1789744883,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals' (XENE) enrollment pause in an ongoing phase 3 trial of azetukalner adds risk to the experimental treatment's expansion into major depressive disorder and bipolar depression, but","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668771921","title":"Xenon Pharmaceuticals Down over 28%, on Pace for Largest Percent Decrease Since March 2017","url":"https://stock-news.laohu8.com/highlight/detail?id=2668771921","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668771921?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:41","pubTimestamp":1789742460,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals Inc.  is currently at $41.09, down $16.26 or 28.35%--Would be lowest close since Feb. 5, 2026, when it closed at $40.39--On pace for largest percent decrease since March 24, 2017, when it fell 52.79%--Snaps a two-day winning streak--Down 29.94% this week; worst weekly performance since the week ending March 24, 2017, when it fell 42.59%--Down 31.77% month-to-date--Down 8.32% year-to-date--Down 42.09% from its all-time closing high of $70.96 on July 9, 2026--Up 11.2% from 52 weeks ago , when it closed at $36.95--Down 42.09% from its 52-week closing high of $70.96 on July 9, 2026--Up 12.51% from its 52-week closing low of $36.52 on Sept. 25, 2025--Traded as low as $39.83; lowest intraday level since Jan. 20, 2026, when it hit $39.29--Down 30.55% at today's intraday low; largest intraday percent decrease since March 24, 2017, when it fell as much as 56.35%All data as of 10:38:06 AM ETSource: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","XENE","SBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668600921","title":"Xenon Pharmaceuticals falls -29.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668600921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668600921?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:05","pubTimestamp":1789740325,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals (XENE) is down -29.8%, or -$17.08 to $40.27. Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-falls-29-8-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-falls-29-8-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IBRN","SBIO","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159002773","title":"Netflix Down 6% On Wells Fargo Downgrade; Xenon Halts Depression Drug Trial Enrollment On Side-Effect Concerns, Shares Plunge 22%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159002773","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159002773?lang=en_us&edition=fundamental","pubTime":"2026-09-18 21:30","pubTimestamp":1789738223,"startTime":"0","endTime":"0","summary":"S&P 500 futures were relatively unchanged on Friday, a day after the major averages rose following Wednesday’s first Federal Reserve interest rate hike in three years.Futures tied to the broad market...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPYQ","SPYM","NFXL","SPXL","SDS","SPY","SDOW","SPXU","NFLP","SSO","NFLY","NFLW","SPXS","SPDN","SPYU","NFXS","DOG","DDM","SPYH","UDOW","SH","NFLX",".DJI","NFX","MMAX",".IXIC","HIBL","DIA","YSPY","IVV","SMAX","XENE","DMAX","DXD","NFLU","VOO",".SPX","SPUU","UPRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668267719","title":"Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday as Tech Rally Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2668267719","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668267719?lang=en_us&edition=fundamental","pubTime":"2026-09-18 21:21","pubTimestamp":1789737665,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was 0.03% lower and the actively traded Invesco QQQ Trust (QQQ) was 0.2% higher in Friday's premarket activity amid technology gains ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ETH","QQQ","IYW","EQR","XRT","XLE","XENE","FAS","IGM","XLI","CAVA","FDN","RTH.AU","IYJ","VDC","DJX","VHT.AU","IYH","SPY.AU","USO","BP",".DJI","IYK","UNG","IYE","WCN","FAZ","HSBC","RTH","STT","GLD","XLV","XLY","XLK","EETH","WCN.AU","SLV","XSD","VHT","XLF","BETH","SOXX","BITO",".IXIC","SPY","GOOG","GOOGL","VIS","IBB","XLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668573926","title":"U.S. Stocks on the MOVE-CoreWeave, StubHub, Ultragenyx","url":"https://stock-news.laohu8.com/highlight/detail?id=2668573926","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668573926?lang=en_us&edition=fundamental","pubTime":"2026-09-18 21:04","pubTimestamp":1789736682,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-CoreWeave, StubHub, UltragenyxSeptember 18 (Reuters)-The major US stock indexes were set for a subdued open on Friday, as lower oil prices and higher Treasury yields sent ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL6N45A0NR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","AUMI","TRUM","LU0109391861.USD","LU0234572021.USD","LU0788109121.HKD","SGDM","LU0642271901.SGD","LU2462611646.USD","IE00B19Z8X17.USD","HMY","LU2362541273.HKD","BK4220","LU0198837287.USD","NFXL","IE00BQXX3C00.GBP","IE00BKVL7J92.USD","TRGP","LU0672654240.SGD","ETSY","CRWG","GLDN","LU0330918003.SGD","LU0353189680.USD","LU0648001328.SGD","XLC","AU","DSP","LU0210533765.USD","LU0788109394.HKD","PXI","LU0215105999.USD","STUB","LU0234570918.USD","LU0477156953.USD","SBIO","BK4116","BK4139","LU0612318385.USD","LU0654597011.USD","LU1883866441.USD","BK4017","NFX","LU0345780521.USD","BK4522","LU1223083913.SGD","GDMN","LU0130517989.USD","LU0345780950.USD","LU0640476718.USD","LU2543165471.USD","LU1223082519.USD","IE00B19Z9505.USD","IE00BWXC8680.SGD","LU0612318971.USD","SGXZ23171101.USD","LU0106261372.USD","CWII","NFLP","LU2860962120.EUR","SG9999001143.SGD","FMTL","LU0130102774.USD","LU2552382215.SGD","LU1429558221.USD","LU2087625088.SGD","CORD","LU0170899867.USD","BK4192","LU0345780281.USD","LU0498741114.HKD","LU1720051017.SGD","LU0303823156.USD","BK4585","LU0278409577.USD","LU1814569148.SGD","NEMG","LU1548497426.USD","NFLU","LU1435385759.SGD","IE00BKDWB100.SGD","LU1102505762.USD","BK4108","CRWX","NFLY","LU2498475776.HKD","BK4570","LU0942090050.USD","LU1366192091.USD","LU1069344957.HKD","NEM","LU0266512127.USD","SNFLXmain","BK4527","LU1674673428.USD","MLPX","LU1430597077.USD","LU1280957306.USD","LU2361045086.USD","SGXZ81514606.USD","XENE","LU0082616367.USD","LU0786609619.USD","LU2461242641.AUD","LU0075056555.USD","SGXZ99366536.SGD","LU2896262040.SGD","LU2552382058.USD","AGMI","LU0368265418.SGD","IE0002270589.USD","AUAU","LU0303821028.USD","LU1823568750.SGD","BK4144","CWVX","BK4551","LU0496367417.USD","LU1979441026.SGD","LU0300736062.USD","LU2362541513.USD","BUZZ","SGXZ51526630.SGD","LU0320765059.SGD","LU0079474960.USD","LU0256863811.USD","LU2237957902.USD","LU1223082196.USD","LU1868838027.USD","UMI","LU0127658192.USD","LU0345781412.USD","LU1102505929.USD","LU0630314457.HKD","LU0868494708.USD","IE00BQXX3F31.USD","NWMX","LU0225283273.USD","MLPI","AFK","LU1861559042.SGD","BK4534","BK4566","LU1989764664.SGD","LU1064131342.USD","NFLW","LU2449327464.USD","LU2357305700.SGD","LU2237957811.SGD","NFXS","LU1127390331.HKD","GFI","GOAU","LU1035775433.USD","LU1720051108.HKD","BK4532","LU0300736492.USD","LU2361044865.SGD","TPZ","LU0143863784.USD","LU2362540622.SGD","BK4122","LU1267930730.SGD","BK4533","LU1232071149.USD","LU0353189763.USD","LU1674673691.USD","LU0143863198.USD","LU0719512351.SGD","IE00B19Z8W00.USD","LU0210536198.USD","LU0708995401.HKD","GXPC","LU0054578231.USD","IE00B1XK9C88.USD","LU0203202063.USD","LU1235294995.USD","BK4598","LU1316542783.SGD","LU0868494617.USD","FCOM","LU0266512473.USD","LU0498741890.SGD","IE00B19Z3B42.SGD","LU2108987350.USD","LU1868837565.USD","LU0368265764.SGD","BK4524","LU0077335932.USD","LU0724618789.USD","BK4023","LU0256863902.USD","BK4548","LU0097036916.USD","LU1988902786.USD","SG9999004303.SGD","BK4581","BK4587","LU0456854461.SGD","LU1778281490.HKD","LU2326559502.SGD","IE00BKPKM429.USD","SLVP","LU0417517546.SGD","RARE","LU0980610538.SGD","LU1046421795.USD","CRWU","BK4507","IE00BZ1G4Q59.USD","LU1201861249.SGD","LU0006306889.USD","LU0882574139.USD","LU0203201768.USD","LU2552382132.HKD","LU2264538146.SGD","LU1023059493.AUD","IE00B19Z3581.USD","LU0788108826.HKD","BK4588","IE00BQXX3D17.EUR","NFLX","LU0122376428.USD","LU2361044949.HKD","IBRN","LU0055631609.USD","CRWV","GDX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xenon-pharma.com;investor.xenon-pharma.com","stockEarnings":[{"period":"1week","weight":-0.0506},{"period":"1month","weight":-0.39},{"period":"3month","weight":-0.4971},{"period":"6month","weight":-0.425},{"period":"1year","weight":-0.1807},{"period":"ytd","weight":-0.234}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0383},{"period":"6month","weight":0.0868},{"period":"1year","weight":0.1603},{"period":"ytd","weight":0.1318}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, a Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epileptic encephalopathy; and XEN1101, a Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.008322},{"month":2,"riseRate":0.75,"avgChangeRate":0.076063},{"month":3,"riseRate":0.25,"avgChangeRate":-0.040327},{"month":4,"riseRate":0.5,"avgChangeRate":0.017963},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.036246},{"month":6,"riseRate":0.5,"avgChangeRate":0.038173},{"month":7,"riseRate":0.416667,"avgChangeRate":0.020725},{"month":8,"riseRate":0.666667,"avgChangeRate":0.065529},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.085824},{"month":10,"riseRate":0.416667,"avgChangeRate":0.043959},{"month":11,"riseRate":0.727273,"avgChangeRate":0.050412},{"month":12,"riseRate":0.666667,"avgChangeRate":0.089745}],"exchange":"NASDAQ","name":"Xenon Pharmaceuticals","nameEN":"Xenon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xenon Pharmaceuticals(XENE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Xenon Pharmaceuticals(XENE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Xenon Pharmaceuticals,XENE,Xenon Pharmaceuticals股票,Xenon Pharmaceuticals股票老虎,Xenon Pharmaceuticals股票老虎国际,Xenon Pharmaceuticals行情,Xenon Pharmaceuticals股票行情,Xenon Pharmaceuticals股价,Xenon Pharmaceuticals股市,Xenon Pharmaceuticals股票价格,Xenon Pharmaceuticals股票交易,Xenon Pharmaceuticals股票购买,Xenon Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xenon Pharmaceuticals(XENE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Xenon Pharmaceuticals(XENE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}